| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 06/15/2005 | CN1205999C Liposone composition and method for administration of a radiosensitizer |
| 06/15/2005 | CN1205997C Method of increasing bone toughness and stiffness and reducing fractures |
| 06/15/2005 | CN1205996C Mannan peptide freeze dried pwoder ampoule for injection |
| 06/15/2005 | CN1205994C Pulmonary delivery of active agents |
| 06/15/2005 | CN1205993C Huaaidan pellet medicine for treating cancer and preparation method thereof |
| 06/15/2005 | CN1205992C Medicine for treatment of ischemic necrosis of fermoral head |
| 06/15/2005 | CN1205984C Medicine composition with synergrstic action and preparation process and use thereof |
| 06/15/2005 | CN1205983C Method for making capsule for promoting promoting blood-circulation and relieving pain |
| 06/15/2005 | CN1205982C drop liquid for treating angiocardiopathy |
| 06/15/2005 | CN1205979C Externally used shengji paste |
| 06/15/2005 | CN1205976C Preparing method for removing impurities in Chinese herbal preparations |
| 06/15/2005 | CN1205973C Chinese medicinal granular for reating diabetes |
| 06/15/2005 | CN1205970C Toxin expelling and face nursing aloe capsule and its making process |
| 06/15/2005 | CN1205969C Ointment of Chinese traditional medicine for curing fever and cough |
| 06/15/2005 | CN1205968C Burn reating Chinese medicine liquid and its prepn |
| 06/15/2005 | CN1205959C Plaster for treating arthritis and cervical vertebra and vertebra lumbalis diseases |
| 06/15/2005 | CN1205941C Puerarin oral preparation and its preparation method |
| 06/15/2005 | CN1205936C Novel contraceptive medicament and method for producing the same |
| 06/15/2005 | CN1205933C Slow-releasing acipimox capsule |
| 06/15/2005 | CN1205931C Pharmaeutical agent comprising benzamide derivative as active ingredient |
| 06/15/2005 | CN1205929C Local administration preparation |
| 06/15/2005 | CN1205925C Process for synthesizing carrier to control medicine release |
| 06/15/2005 | CN1205924C Method for wrapping kmedicine by liposome |
| 06/15/2005 | CN1205923C Liposome-entrapped topoisomerase inhibitors |
| 06/15/2005 | CN1205922C Preparation of aqueous clear solution dosage forms with bile acids |
| 06/15/2005 | CN1205921C Long acting injectable formulations contg. hydrogenated castor oil |
| 06/15/2005 | CA2489735A1 Method and device for minimally invasive implantation of biomaterial |
| 06/14/2005 | US6906106 Compositions for the skin comprising fibers and ubiquinones and methods of using the same |
| 06/14/2005 | US6906086 Methods for inhibiting bone loss |
| 06/14/2005 | US6906043 Rapidly soluble film preparation |
| 06/14/2005 | US6906042 Micelles |
| 06/14/2005 | US6906031 Polyacid glycopeptide derivatives |
| 06/14/2005 | US6906030 Carbon-substituted diketopiperazine delivery systems |
| 06/14/2005 | US6906028 Stable insulin formulations |
| 06/14/2005 | US6906027 Composition for nasal administration of insulin |
| 06/14/2005 | US6905709 Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer |
| 06/14/2005 | US6905708 Bupropion hydrochloride in protective coating; side effect reduction |
| 06/14/2005 | US6905707 Controlling concentration of enzyme inhibitor in blood; enteric coating |
| 06/14/2005 | US6905701 Formulations for transmucosal vaginal delivery of bisphosphonates |
| 06/14/2005 | US6905700 Interpenetrating polymer network containing hydrophobic, hydrophilic polymers; sustained release; crosslinked, three-dimensional structure |
| 06/14/2005 | US6905692 Suitable for topical application to skin or mucosal membranes of a mammal, which are utilized to inhibit the growth of bacteria, yeasts, fungi, viruses |
| 06/14/2005 | US6905687 Fusion proteins; immunogens; solid phase synthesis; kits |
| 06/14/2005 | US6905675 Sulfur containing dermatological compositions and methods for reducing malodors in dermatological compositions |
| 06/14/2005 | US6905431 Color changing balls and toys |
| 06/14/2005 | US6905239 Sprinkling method for preparing powder formulations |
| 06/14/2005 | US6905016 Packaging system for transdermal drug delivery systems |
| 06/14/2005 | CA2459239C Hydrogenated castor oil dispersed in a lipid for pharmaceutically elegant topical ointment |
| 06/14/2005 | CA2400318C Botulinum toxin pharmaceutical compositions |
| 06/14/2005 | CA2346567C Method for preparing a solution for nasal spray containing sex hormones and a cyclodextrin |
| 06/14/2005 | CA2337188C Composite structure with adhesive matrix containing one or more active substances |
| 06/14/2005 | CA2327285C Stabilized pharmaceutical preparations of gamma-aminobutyric acid derivatives and process for preparing the same |
| 06/14/2005 | CA2248582C Process for producing efonidipine hydrochloride preparations |
| 06/14/2005 | CA2246708C Vaccine for b-cell malignancies |
| 06/14/2005 | CA2187447C Hydrofluorocarbon propellant containing medicinal aerosols |
| 06/14/2005 | CA2175050C Liposomes and liposome vesicle precursors with porous expanded structure |
| 06/14/2005 | CA2171911C Drug flux enhancer-tolerant pressure sensitive adhesive composition |
| 06/09/2005 | WO2005052008A1 NONREDUCING β-GLUCAN DERIVATIVE |
| 06/09/2005 | WO2005051982A1 Glycopeptides and temperature-responsive micelles |
| 06/09/2005 | WO2005051902A2 MODIFIED MscL PROTEIN CHANNEL |
| 06/09/2005 | WO2005051871A2 Implantable sensors and implantable pumps and anti-scarring agents |
| 06/09/2005 | WO2005051511A1 Method for producing fine organic compound particles |
| 06/09/2005 | WO2005051489A2 Fast dissolving solid oral dosage forms of galanthamine |
| 06/09/2005 | WO2005051487A2 A ruminant zinc containing bolus |
| 06/09/2005 | WO2005051485A1 Peptidically buffered formulations for electrotransport applications and methods of making |
| 06/09/2005 | WO2005051484A1 Methods for preparing polymeric buffer formulations for electrotransport applications |
| 06/09/2005 | WO2005051483A2 Electrical devices and anti-scarring agents |
| 06/09/2005 | WO2005051476A1 Method and system for rapid transdermal administration |
| 06/09/2005 | WO2005051456A2 Composition and apparatus for transdermal delivery |
| 06/09/2005 | WO2005051451A2 Electrical devices and anti-scarring agents |
| 06/09/2005 | WO2005051444A2 Soft tissue implants and anti-scarring agents |
| 06/09/2005 | WO2005051428A2 Method for obtaining a thermoreversible gel with a controlled three-dimensional structure, and gel obtained |
| 06/09/2005 | WO2005051418A2 Pharmaceutical formulations for the sustained release of interleukins and therapeutic applications thereof |
| 06/09/2005 | WO2005051417A1 Pharmaceutical formulations for the sustained release of interferons and therapeutic applications thereof |
| 06/09/2005 | WO2005051416A1 Pharmaceutical formulations for the sustained release of one or more active principles and applications thereof, such as therapeutic applications |
| 06/09/2005 | WO2005051384A1 Stabilised pharmaceutical compositions |
| 06/09/2005 | WO2005051374A1 Tablets of citalopram hydrobromide |
| 06/09/2005 | WO2005051370A1 Composition having liver function protective effect |
| 06/09/2005 | WO2005051368A2 Phosphodiesterase v inhibitor formulations |
| 06/09/2005 | WO2005051365A1 Composition and device for facilitating venipuncture |
| 06/09/2005 | WO2005051364A1 Film-forming composition suitable for hard capsules and method for preparing the same |
| 06/09/2005 | WO2005051362A2 Oral benzimidazole compositions comprising an active core, an optional separating layer and an enteric coating |
| 06/09/2005 | WO2005051361A1 Colonic purgative composition with soluble binding agent |
| 06/09/2005 | WO2005051360A1 Pharmaceutical compositions comprising nateglinide and a surfactant |
| 06/09/2005 | WO2005051359A1 Macromolecular drug complexes having improved stability and therapeutic use of the same |
| 06/09/2005 | WO2005051358A1 Composition and method for enhancing bioavailability |
| 06/09/2005 | WO2005051357A1 Antiangiogenic agents |
| 06/09/2005 | WO2005051356A1 Novel nimesulide compositions |
| 06/09/2005 | WO2005051355A1 Solid forms of anti-egfr-antibodies |
| 06/09/2005 | WO2005051354A1 Controlled food effect composition |
| 06/09/2005 | WO2005051353A2 Pharmaceutical formulations comprising voriconazole |
| 06/09/2005 | WO2005051352A1 Veterinary compositions for treating mastitis |
| 06/09/2005 | WO2005051351A2 Gene delivery mediated by liposome-dna complex with cleavable peg surface modification |
| 06/09/2005 | WO2005051350A2 Water dispersible tablet |
| 06/09/2005 | WO2005051349A2 Pharmaceutical compositions of mirtazapine |
| 06/09/2005 | WO2005051348A2 Enteric-coated tablets of pantoprazole |
| 06/09/2005 | WO2005051347A2 A simple process and formulation for making taste- masked ibuprofen liquid preparations and similar good-tasting preparation of other pharmaceutically active or bitter, poor tasting compounds for the production of liquid preparations |
| 06/09/2005 | WO2005051346A2 Compositions comprising organic compounds |
| 06/09/2005 | WO2005051345A1 Tirofiban for inhalative administration for the treatment of diseases that are caused by thrombosis |
| 06/09/2005 | WO2005051344A2 Oral solid instant-release dosage forms comprising finasteride and an anionic surfactant-methods of manufacturing thereof |
| 06/09/2005 | WO2005051342A1 Antimicrobial compositions containing an aromatic carboxylic acid and a hydric solvent |